98631-72-2

Basic information

• Product Name: 2-Propenoyl chloride, 3-[3,4-bis(acetyloxy)phenyl]-, (2E)-
• CAS NO: 98631-72-2
• Molecular Formula: C13H11ClO5
• Molecular Weight: 282.68
• Mol File: 98631-72-2.mol
• Article Data: 60

Chemical Properties

• CAS DataBase Reference: 2-Propenoyl chloride, 3-[3,4-bis(acetyloxy)phenyl]-, (2E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propenoyl chloride, 3-[3,4-bis(acetyloxy)phenyl]-, (2E)-(98631-72-2)
• EPA Substance Registry System: 2-Propenoyl chloride, 3-[3,4-bis(acetyloxy)phenyl]-, (2E)-(98631-72-2)

Safety Data

• Hazardous Substances Data: 98631-72-2(Hazardous Substances Data)

Upstream product

• 331-39-5 caffeic acid 
• 13788-48-2 di-O-acetylcaffeic acid 
• 331-39-5 caffeic acid 
• 88623-81-8 3,4-diacetoxycinnamic acid 
• 79-37-8 oxalyl dichloride 
• 108-24-7 acetic anhydride 
• 67727-64-4 3,4-diacetoxybenzaldehyde 

Downstream Products

• 875544-29-9 (E)-3-(3,4-Diacetoxy-phenyl)-acrylic acid 2-phenylselanyl-ethyl ester 
• 1073897-83-2 1,4,5-tri-O-caffeoylquinic acid 
• 14534-61-3 4,5-di-O-caffeoylquinic acid 
• 6082-42-4 3-O-caffeoyl-γ-quinide 
• 918407-45-1 4-O-caffeoyl-1,5-quinide 

Relevant articles and documents

Development trans-N-benzyl hydroxyl cinnamamide based compounds from cinnamic acids and characteristics anticancer potency

The derivatization of three hydroxycinnamamides becomes trans-N-benzylhydroxycinnamamides, and their potential assay as anticancer agents has been carried out. N-benzyl-p-coumaramide (5a), N-benzylcaffeamide (5b), and N-benzylferulamide (5c) were obtained

Novel 3C-like protease inhibitor as well as preparation method and application thereof

The invention provides a novel 3C-like protease inhibitor which is 3 ", 4" - O - diacetyl -epicatechin trans-caffeic acid ester with a specific structure. The invention further provides a preparation method and application of the 3C-like protease inhibitor. The invention has the advantages that the compound 3 ", 4" - O - diacetyl - epicatechin trans-caffeic acid ester is designed and synthesized based on the structure of epicatechin; even when the concentration is low, the activity of 3C-like protease in the novel coronavirus can be obviously inhibited. The compounds can be used as 3C-like protease inhibitors and are used for preparing anti-novel coronavirus SARS-CoV - 2 infection drugs.

Synthesis of novel caffeic acid derivatives and their protective effect against hydrogen peroxide induced oxidative stress via Nrf2 pathway

Aim: This study was aimed to synthesize novel caffeic acid derivatives and evaluate their potential applications for the treatment of oxidative stress associated disease. Main methods: Caffeic acid sulfonamide derivatives were synthesized by coupling sulf